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Common variants at 5q33.1 predispose to migraine in African-American children AbsTrACT background genome-wide association studies (gWaSs) have identified multiple susceptibility loci for migraine in european adults. However, no large-scale genetic studies have been performed in children or african americans with migraine. Methods We conducted a gWaS of 380 africanamerican children and 2129 ancestry-matched controls to identify variants associated with migraine. We then attempted to replicate our primary analysis in an independent cohort of 233 african-american patients and 4038 non-migraine control subjects. results the results of this study indicate that common variants at 5q33.1 associated with migraine risk in african-american children (rs72793414, p=1.94×10 −9 ). the association was validated in an independent study (p=3.87×10 −3 ) for an overall meta-analysis p value of 3.81×10 −10 . eQtl (expression quantitative trait loci) analysis of the genotype-tissue expression data also shows the genotypes of rs72793414 were strongly correlated with the mrna expression levels of NMUR2 at 5q33.1. NMUR2 encodes a g protein-coupled receptor of neuromedin-U (nMU). nMU, a highly conserved neuropeptide, participates in diverse physiological processes of the central nervous system. Conclusions this study provides new insights into the genetic basis of childhood migraine and allow for precision therapeutic development strategies targeting migraine patients of african-american ancestry.
InTroduCTIon
Migraine is a common neurological disorder characterised by recurrent and intense headaches. 1 Although the mechanism of migraine is still unknown, migraines are believed to be caused by the interactions of multiple environmental and genetic factors. 1 Twin studies have revealed heritability estimates of migraine ranging from 34% to 51%.
2 Consistent with the high heritability estimates, genome-wide association studies (GWASs) of European adults have successfully identified many migraine susceptibility genes involved in neuronal and vascular mechanism. 3 4 As the origins of migraine can be traced into childhood and adolescence for many adult sufferers, the early onset of migraine may reflect elevated biological predisposition or increased susceptibility to environmental risk factors. In addition, as the prevalence of migraines varies across ethnicities, the genetic risk factors may be different in African ancestries and European ancestries. To our knowledge, no largescale GWAS has been performed in either children or African Americans with migraine.
MeThods sample collection
Case subjects were defined as subjects with a diagnosis of migraine (ICD9 (International Classification of Diseases, ninth revision) code: 346.00-346.93) and registered through the electronic medical record (EMR) of the Children's Hospital of Philadelphia (CHOP). All patients fulfilled the International Headache Society diagnostic criteria (ICHD-3b) 5 for migraine. The number of patients diagnosed with migraine with and without aura was provided in online supplementary table S1.
All blood samples were collected at the time of diagnosis, and most were annotated with clinical information comprising gender and age at diagnosis. Control subjects were recruited from the Philadelphia region through the CHOP Healthcare Network, including four primary care clinics and several group practices and outpatient practices that included well -child visits. Eligibility criteria for control subjects were (1) self-reporting as Caucasian or African American, (2) availability of 1.5 µg of high -quality DNA from peripheral blood mononuclear cells and (3) no serious underlying medical disorder, including mental disorders (ICD9 code: 290.0-319). The Research Ethics Board of CHOP provided written informed consent from all subjects by nursing and medical assistant staff under the direction of CHOP clinicians. SNP genotyping was performed using the Illumina Infinium II HumanHap550 and Human Quad610 BeadChips.
TaqMan snPs and genotyping
Selection of SNPs were conducted based on information from the dbSNP database (http:// www. ncbi. nlm. nih. gov/ projects/ SNP/). Two polymorphisms, rs1946225 and rs72793414, were included for the genotyping tests. Real-time PCR using the following calculations: 2.5 µL Genotyping Master Mix, 0.25 µL SNP assay probes and 2.25 µL DNA template (at 5 ng/µL=11.25 ng total). Thermal cycling conditions were as follows: 60°C 30 s pre-read, 95°C for 10 min, followed by 40 cycles at 95°C for 15 s and at 60°C for 1 min, then 60°C 30 s post-read. Genotyping of the polymorphisms were carried out using the 5′ exonuclease TaqMan Allelic Discrimination assay, which was Genome-wide studies performed using minor groove binder probes fluorescently labelled with VIC or FAM and the protocol recommended by the supplier (Applied Biosystems, Foster City, California, USA). Analysis for interpretation was performed with Via7 software and Taqman Genotyper software calling.
Quality control
Individuals were genotyped on the HumanHap550 v1, HumanHap550 v3 and Human Quad610 arrays. SNPs were further filtered with genotype missing rate, minor allele frequency and Hardy-Weinberg equilibrium p value. The analysis was implemented in PLINK. 6 After quality control, 506 950 and 522 471 SNPs were kept for the association analysis of the European-American and African-American cohort, respectively. Here, we only considered samples with a genotype call rate no less than 95%. To remove cryptic relatedness between samples, we calculated the identity-by-descent (IBD) scores and remove one individual in the pairs of subjects with IBD great than 0.25. We also conducted principal component analysis among three cohorts separately using EIGENSTRAT to detect and correct for potential substructures and outliers. 
Local ancestry estimation
We used MULTIMIX to infer the local ancestry of our African-American data. 8 The reference data of African (code: YRI) and European (code: CEU) ancestries were downloaded from the 1000 Genome Project.
statistical analysis
The association analysis were carried out in PLINK using both allelic association test and logistic regression model. For the association test of logistic regression model, we used age, gender and the first 10 PCs (principal components) as covariates. The genomic inflation factor of migraine GWAS in African-American children was 1.01 for the logistic association. Meta-analysis was performed by GWAMA. 9 Fixed-effects p values were reported. Genotype imputation at the 3q25.32 locus was performed with IMPUTE2 using the reference panel 1000 Genome Phase I integrated variants set (Dec 2013 release), 10 which is provided as a single worldwide haplotype file per chromosome (rather than splitting the files by population or group). We used SHAPEIT to infer the haplotypes before imputation. 11 In consideration of the uncertainty of imputation, association analysis of the imputed genotypes was calculated with the SNPTEST V.2 package.
12 resuLTs
Association analysis
To identify genes associated with susceptibility to childhood migraine, we genotyped 1267 DNA samples isolated from blood obtained from children with history of migraine, who were receiving their care at CHOP. Blood-derived DNAs from 9693 children without migraine/headache diagnosis were genotyped as controls. All subjects were genotyped using the Illumina HumanHap550 or 610 SNP array. After completion of population stratification and quality control measures, our data set was composed of 380 patients with migraine and 2129 controls for the African-American (AA) children, and 599 patients with migraine and 7327 controls for the European-American (EA) children (online supplementary figure S1 and table S2). We tested associations between SNP markers and migraine.
As no genome-wide significant signal was identified in the EA children, we examined for associations at loci previously reported in European adults. 3 4 The 1p13.1 and 2q37.1 loci revealed a nominal significance in a meta-analysis of our paediatric cohorts (rs2078371, p=0.034; rs7577262, p=0. −8 after adjustment for age, gender and the first 10 PCs. The genomic inflation factor of logistic model is 1.01. We also examined the association of rs1946225 in the EA paediatric cohort and found that this locus was not significant in the EA children with migraine (p logistic =0.39), suggesting that the 5q33.1 locus might be specifically associated with the migraine risk in African Americans.
Imputation of 5q33.1
To investigate the 5q33.1 region in greater detail and search for additional variants not assayed on the genotyping arrays directly, we imputed unobserved genotypes at 5q33.1 in the AA migraine cohort using the 1000 Genomes Project data as reference. In the AA children, imputation identified 83 additional SNPs surpassing genome-wide significance with the top imputed SNP, rs72793414, having p=1.94×10 −9 (online supplementary table S5). As shown, the genome-wide significant SNPs, both genotyped and imputed, were highly correlated in a strong LD region ( figure 1A) .
To explore additional GWAS signals at this region, we conditioned the analysis on the top imputed SNP rs72793414 in the AA children. The association signal at 5q33.1 was abolished, including the top genotyped SNP rs1946225 (p=0.828), after conditioning on rs72793414 suggesting no additional signal at this region (online supplementary figure S5 ).
replication genotyping
To further confirm the association between 5q33.1 and migraine, we identified an independent AA paediatric cohort of 233 patients with migraine and 4038 non-migraine control subjects, all of African-American ancestry based on self-reported information within the EMRs at CHOP. We next designed TaqMan genotyping assays for rs1946225 (top genotyped SNP) and rs72793414 (top imputed SNP) to determine the genotypes of the two SNPs in the migraine cases. The controls were already genotyped by the Illumina HumanHap550 or 610 SNP arrays.
We further assessed the SNP-trait associations of the two SNPs. The associations of both SNPs were successfully validated in the replication cohort (table 1). The p values of both markers were significant after Bonferroni correction (rs1946225, p corrected =0.03; rs72793414, p corrected =7.74×10 −3 ). In addition, the ORs of rs72793414 are comparable between the discovery and replication studies (table 1) . Meta-analysis on rs1946225 and rs72793414 after combining the discovery and replication cohorts revealed genome-wide significant p values for both SNPs (rs1946225, p combined =9.55×10 −9 ; rs72793414, p combined =3.81×10 −10 ).
Admixture analysis
Given that AAs in general have a proportion of admixture from European populations (~15%-20%), we investigated the local ancestry of the participating AA individuals at 5q33.1. The estimation of the African ancestry at 5q33.1 from our study is consistent with previous reports. 13 14 Both cases and controls show African ancestry between 80% and 85% (online supplementary figure S6 ). The proportion of European and African ancestry at 5q33.1 was balanced between cases and controls (Wilcoxon rank-sum test, p=0.367), suggesting that the association detected at 5q33.1 is not driven by local ancestry Genome-wide studies 
eQTL analysis
We next sought to determine if the genotypes of rs1946225 and rs72793414 were correlated with the mRNA expression levels of NMUR2. The eQTL data from Genotype-Tissue Expression (GTEx) 15 demonstrated that the expression of NMUR2 was significantly downregulated in the frontal cortex (rs1946225, p=1.50×10 −9 ; rs72793414, p=8.50×10 −10 , figure 1B and table 2) and thyroid tissue (rs1946225, p=5.40×10 −14 ; rs72793414, p=6.40×10 −14 , table 2) of individuals carrying the minor alleles of rs1946225 and rs72793414 (online supplementary figure S7 ). The minor alleles of rs1946225 and rs72793414 represented the risk variants for migraine in the AA children. Interestingly, besides NMUR2, the minor alleles of rs1946225 and rs72793414 were also negatively associated with the expression levels of GLRA1 in the cerebellar hemisphere (rs1946225, p=1.00×10 −9 ; rs72793414, p=7.70×10 −10 ; table 2). GLRA1 encodes glycine receptor subunit alpha-1, which is located at about 500 kb upstream from the LD block of migraine associated SNPs in AA children. We further confirmed that both NMUR2 and GLRA1 are highly expressed in a variety of brain tissues of human according to the GTEx data (online supplementary figure  S8 ), suggesting a functional role for NMUR2 and GLRA1 in the central nervous system (CNS). Taken together, the eQTL data indicated that either rs1946225 and rs72793414 or variants in strong LD with them may be responsible for the regulation of NMUR2 and GLRA1 expression in brain tissues, and that low expression levels of NMUR2 and GLRA1 are likely linked to the pathophysiology of migraine.
In silico mining of putative causal variants at 5q33.1
Since all the genome-wide significant SNPs are non-coding (online supplementary table S5), we further explored the bioinformatic annotations of top imputed SNP rs72793414 and variants in the same LD block with rs72793414 (r 2 >0.8) using HaploReg V.4.1. 16 HaploReg annotation results indicate a number of SNPs in the LD block with rs72793414 are located in the regulatory region of genome. For example, rs72793414 may influence nine regulatory motifs as predicted by the position weight matrix (PWM) method suggesting rs72793414 could involve in the regulation process of its nearby genes. In addition, the annotation of top genotyped SNP rs1946225 (r 2 =1 and D′=1 with rs72793414) based on the full table of epigenomic information from Roadmap Epigenomics 17 indicates there is a cluster of enhancer activity in the brain, and that it is classified as an enhancer (7_Enh) 
dIsCussIon
In this study, we have identified a genomic locus at 5q33.1 that is associated with migraine in AA children. The locus was not associated with migraine in EA children implying that the causal variants are either not present in EA or are not tagged by the AA migraine-associated SNPs. Analysis of eQTL data demonstrates that associated SNPs may regulate expression levels of nearby genes NMUR2 and GLRA1. This discovery contributes to our understanding of the genetic aetiology of migraine in AAs and provides a novel gene target for therapeutic development.
The eQTL results further indicate that detected risk variants can lead to significant expression changes of NMUR2 and GLRA1 expression in brain tissues. NMUR2 is a G protein-coupled receptor of NMU, a highly conserved neuropeptide, and participates in diverse physiological processes such as cardiovascular effects, smooth-muscle contraction, energy homoeostasis, nociception and stress response. [18] [19] [20] [21] [22] NMUR2 is predominantly expressed in the CNS. 23 Accumulated evidence from the animal models suggests that NMU and NMUR2 in the CNS mediate the regulation of food intake, energy balance, stress response and nociception. For example, NMU knockout mice exhibit increased body weight and adiposity. 21 NMUR2 knockdown rats display significantly greater consumption of high-fat diet leading to increased body weight. 24 Central administration of NMU elevates adrenocorticotropin and corticosterone release, 19 and stimulates stress-related behaviours in rodents, 22 whereas NMU knockout mice show blunted behavioural response to environmental stress. 20 In addition, both NMU and NMUR2 knockout mice display reduced nociceptive responses. 18 20 23 Although no functional link between NMUR2 and migraine has been established to this point, hormone imbalance, stress, obesity and nociceptor activation are believed to be triggers or risk factors for migraine. [25] [26] [27] The protein encoded by GLRA1 is a neurotransmitter-gated transmembrane ion channel, which mediates postsynaptic inhibition in the CNS. Defects of GLRA1 can cause a rare neurological disorder, hyperekplexia. 28 It is well known that disruptions of three ion channel genes CACNA1A, ATP1A2 and SCN1A are responsible for most familial hemiplegic migraine. 29 Previous GWASs of migraine have implicated genes involved in neurotransmitter release pathways, 4 29 suggesting that GLRA1 could influence the risk of migraine through mediating neurotransmission processes. In addition, eQTL results suggest that expression levels of NMUR2 are also significantly correlated with rs72793414 and rs1946225 genotypes in thyroid. Consistent with this, a few studies suggest that hypothyroidism and migraine could be linked, [30] [31] [32] suggesting that altered expression levels of NMUR2 in thyroid gland could also play a role in migraine. We further examined if potential interactants of NMUR2 or GLRA1 may be associated with migraine. No significant association of variants from NMU or GLRB was found.
Consistent with eQTL results, bioinformatic annotations of variants detected provided multiple lines of evidence that SNPs from this GWAS may affect the regulatory mechanisms at 5q33.1. For example, ChIP-seq and motif data suggest that CTCF binding affinity to the alleles of rs4958306 could be different and further influence the expression of nearby genes such as NMUR2 and GLRA1.
In summary, we performed the first large-scale GWAS of migraine in children, including both EA and AA ancestry, and identified a novel migraine risk locus at 5q33.1 in the AA children. The eQTL analysis implicated two genes NMUR2 and GLRA1 both involved in signalling of neural pathways in the CNS. Follow-up studies of NMUR2 and GLRA1 may provide new insights into the genetic basis of childhood migraine and allow for precision therapeutic development strategies targeting migraine patients of AA ancestry.
